The ever-increasing incidence of antibiotic-resistant infections combined with a weak pipeline of new antibiotics has created a global public health crisis 1 . Accordingly, novel strategies for enhancing our antibiotic arsenal are needed. As antibiotics kill bacteria in part by inducing reactive oxygen species (ROS) 2-4 , we reasoned that targeting microbial ROS production might potentiate antibiotic activity. Here we show that ROS production can be predictably enhanced in Escherichia coli, increasing the bacteria's susceptibility to oxidative attack. We developed an ensemble approach of genome-scale, metabolic models capable of predicting ROS production in E. coli. The metabolic network was systematically perturbed and its flux distribution analyzed to identify targets predicted to increase ROS production. Targets that were predicted in silico were experimentally validated and further shown to confer increased susceptibility to oxidants. Validated targets also increased susceptibility to killing by antibiotics. This work establishes a systems-based method to tune ROS production in bacteria and demonstrates that increased microbial ROS production can potentiate killing by oxidants and antibiotics.
l e t t e r s
The ever-increasing incidence of antibiotic-resistant infections combined with a weak pipeline of new antibiotics has created a global public health crisis 1 . Accordingly, novel strategies for enhancing our antibiotic arsenal are needed. As antibiotics kill bacteria in part by inducing reactive oxygen species (ROS) [2] [3] [4] , we reasoned that targeting microbial ROS production might potentiate antibiotic activity. Here we show that ROS production can be predictably enhanced in Escherichia coli, increasing the bacteria's susceptibility to oxidative attack. We developed an ensemble approach of genome-scale, metabolic models capable of predicting ROS production in E. coli. The metabolic network was systematically perturbed and its flux distribution analyzed to identify targets predicted to increase ROS production. Targets that were predicted in silico were experimentally validated and further shown to confer increased susceptibility to oxidants. Validated targets also increased susceptibility to killing by antibiotics. This work establishes a systems-based method to tune ROS production in bacteria and demonstrates that increased microbial ROS production can potentiate killing by oxidants and antibiotics.
Reactive oxygen species (ROS) can damage DNA, RNA, proteins and lipids, resulting in cell death when the level of ROS exceeds an organism's detoxification and repair capabilities. Despite this danger, bacteria growing aerobically generate ROS as a metabolic by-product, a risk balanced by an increased efficiency and yield of energy from growth substrates. At least two possible mechanisms can be used to manipulate bacterial ROS metabolism and increase sensitivity of bacteria to oxidative attack: (i) amplification of endogenous ROS production and (ii) impairment of detoxification and repair systems. Whereas removal of their detoxification and repair systems has been shown to make bacteria more susceptible to oxidants 5, 6 , antibiotics 7 and immune attack 8, 9 , manipulation of endogenous bacterial ROS production remains largely unexplored. Endogenous ROS production has long been appreciated as a factor influencing the ability of an organism to survive oxidative stress 10 , but an inability to predict the outcome of genetic and environmental perturbations on ROS production 11 has hampered exploration of this phenomenon as an antimicrobial adjuvant. What has been missing is a thorough systemslevel understanding of the pathways that produce ROS, which constitute a potentially expansive and highly integrated biochemical reaction network. In this study, we sought to tune E. coli metabolism for increased ROS production (specifically, O 2 − and H 2 O 2 ) and to determine whether this effect can potentiate oxidative stress and antibiotic activity. Our goal was not to overwhelm the oxidative detoxification and repair capabilities of E. coli with endogenously generated ROS, but rather to increase endogenous production such that the ability of E. coli to cope with exogenous oxidative stress would be compromised. We hypothesized that such a strategy would broadly potentiate antimicrobials that harness oxidative stress and provide a general approach for the discovery of antimicrobial adjuvants. To reach this goal, we developed an approach using ensembles of genome-scale, metabolic models to quantitatively estimate ROS production from E. coli metabolism (Fig. 1) .
The sources for the majority of endogenous ROS produced by E. coli remain elusive 11 . The removal of enzymes that generate ROS in vitro has had seemingly little effect on whole-cell ROS production 11 . This can be explained by the potential scope of ROS generators. Previous studies have demonstrated that O 2 − and H 2 O 2 can be produced when O 2 abstracts electrons from reduced flavin, quinol and transition metal functional groups 12, 13 . We inspected E. coli metabolism for enzymes that use these electron carriers and identified 133 reactions, spanning many metabolic pathways, with the potential to generate ROS in the presence of O 2 ( Supplementary Table 1 ). The number of potential ROS-generating reactions is comparable to the number of reactions that generate ATP/ADP, NAD/H and NADP/H, suggesting that ROS could play a crucial, highly integrated role in bacterial metabolism. A quantitative systems-level approach is required to predictably modify the production of such highly connected metabolites, as even removal of enzymes that endogenously produce ROS may increase or decrease production depending on the redistribution of metabolic flux on the remaining ROS-generating enzymes 11 .
Systems-level metabolic modeling has been used extensively to optimize the production of desirable metabolites and has led to advances in biotechnology, metabolic discovery and microbiology 14 .
In this study, we employed flux balance analysis with genome-scale l e t t e r s metabolic models (GSMM) to simulate systems-level ROS production in E. coli. In flux balance analysis, reaction stoichiometries are used to place constraints on a metabolic solution space, and linear programming identifies a flux distribution within that space that optimizes an objective function, which is typically a flux within the system, such as biomass generation. Accuracy within the stoichiometric reaction network is critical to the performance of such constraint-based techniques 15, 16 . Current metabolic reconstructions include consumption reactions, such as superoxide dismutase and catalase, and generation reactions involved in cofactor biosynthesis and alternate carbon metabolism, but are devoid of generation reactions that account for the majority of ROS produced 17 11, 13, 17, 18 , and this framework allowed separate (independent species balances), but simultaneous, modeling of H 2 O 2 and O 2 − production in E. coli. Optimization of an objective function is a critical feature of constraintbased techniques, and maximizing for biomass generation has proven to be effective in predicting redistribution of metabolic flux 19 . However, when presented with competing pathways, constraint-based methods will identify the most efficient pathway in terms of cellular resources as the one that carries flux. ROS-generating reactions are less efficient competing pathways where reducing equivalents are lost to O 2 instead of being transferred to the intended acceptor. Therefore, addition of ROS-generating reactions to a GSMM is necessary to model ROS metabolism, but insufficient because the reactions will not carry flux (Supplementary Methods). To address this, we recognized that ROS-generating reactions are coupled to their more efficient counterpart, in the sense that initial electron transfer from reactant to electron carrier proceeds normally and is dictated by requirements for the intended products, and that it is the promiscuity of the reduced electron carrier with O 2 that generates ROS. Thus, ROS flux is a function of the number of electrons transferred to the electron carrier, and consequently dependent on the reaction flux of the intended reaction. Therefore, in this study, the flux of O 2 − and H 2 O 2 from ROS-generating enzyme i was assumed to be proportional to the reaction flux, v i . This assumption results in proportionality between ROS flux from enzyme i and the number of electrons transferred by enzyme i , and is accomplished by coupling the intended enzyme reaction to both its O 2 − and H 2 O 2 side reactions (Online Methods and Supplementary Methods). This coupling requires specification of the proportion of electrons that flow to O 2 to form O 2 − and H 2 O 2 for each of the 133 potential ROS sources. These values vary considerably from enzyme to enzyme 12, 20 , and are largely undefined owing to the absence of in vivo measurements. With this indeterminacy in mind, we employed an approach using ensembles of models.
Two ensembles of ROS-GSMMs were constructed, each with 1,000 different models (Supplementary Methods). The proportions of electron flow from reaction i to generate O 2 − and H 2 O 2 were captured by the constants c i O , 2 − and c i H O , 2 2 (Supplementary Methods and Supplementary Dataset). One ensemble derived these constants from a Gaussian distribution to model a distributed ROS production network (many significant generators), whereas the other ensemble derived these constants from an exponential distribution to model a centralized ROS production network (few significant generators). Further, it was specified that ROS could only be produced from these reactions and not consumed, with the exception of the O 2 − attack of Fe-S centers, and that the in silico O 2 − and H 2 O 2 production rates of the wild-type GSMM had to match the best available experimental estimates (Online Methods and Supplementary Methods). Thus, every stoichiometric reaction network within the ensembles had the exact same production rate of O 2 − and H 2 O 2 for its wild-type GSMM. Also, the existence of alternative optimal solutions for ROS production of each wild-type network was examined using flux variability analysis. At a biomass production rate of 100%, all wild-type networks generate a unique solution for the flux of H 2 O 2 and O 2 − (Supplementary Methods).
With these ensembles, we explored in silico how perturbations to the metabolic network alter basal ROS production. We performed a systematic gene-deletion analysis in which we removed genes one at a time and recalculated reaction fluxes, while optimizing for biomass generation (Online Methods and Supplementary Methods). This provided quantitative distributions of ROS production (H 2 O 2 and O 2 − ) from mutant E. coli ( Fig. 1 ) and allowed us to identify deletions likely to alter basal ROS production, as measured by the mean ROS production level ( Fig. 2a,b and Supplementary Fig. 1a ).
To account for variable growth rates of mutant strains, we normalized ROS flux by biomass production (BM), and calculations are therefore H 2 O 2 /BM and O 2 − /BM (mmol/g dry weight (DW) produced). From our analysis of bacteria grown in aerobic glucose minimal media (see Supplementary Table 3 for constraints imposed by transcriptional regulation), we identified genes whose deletions were most likely to increase ROS production, including those encoding for ATP synthase (atpA-I), pyruvate dehydrogenase (aceEF, lpd), NADH dehydrogenase complex I (nuoABCE-N), glutamate dehydrogenase (gdhA), cytochrome bo (cyoABCD) and triose phosphate isomerase (tpiA) Figure 1 Systems approach to enhance microbial ROS production. Left, methodology for the development and validation of an ensemble of systems-level models of E. coli metabolism for estimation of basal ROS production. ROS-generating reactions were incorporated into a metabolic reconstruction and flux balance analysis (FBA) framework 17 . Network perturbations by single-gene knockouts were done in silico using FBA to identify alterations that affect ROS production. Right, in silico predictions were evaluated experimentally by generating mutants and measuring their ROS production and susceptibility to killing by oxidants and antibiotics. Trans., transition. Table 4 ). Investigation of the flux distributions for these mutants identified a general trend for ROS production where predicted increases correlated with inefficiencies in the production or usage of ATP.
To validate our approach and in silico analysis, we experimentally tested a series of deletions of genes that encode enzymes within glycolysis, the pentose-phosphate pathway, the Entner-Doudoroff pathway, the TCA cycle, the glyoxylate shunt, aerobic respiration, acetate metabolism and glutamate metabolism (Fig. 2c,d and Supplementary  Fig. 1b ). This collection of enzymes included those predicted to increase ROS (targets) as well as those predicted to leave ROS production unchanged (negative controls). We note that our predictions included all 21 genetic mutants tested, both targets and negative controls, and that only those enzymes that were experimentally tested are levels of various mutants compared to wild type. Blue, strains whose mean H 2 O 2 production levels were simulated to be >5% higher than wild type over both ensembles; yellow, strains whose mean H 2 O 2 production levels were simulated to be <5% higher. (b) Predicted O 2 − levels of various mutants compared to wild type. Blue, strains whose mean O 2 − production levels were simulated to be >5% higher than wild type over both ensembles; yellow, strains whose mean O 2 − production levels were simulated to be <5% higher. (c) Experimentally measured relative fluorescence/A 600 of strains with the H 2 O 2 -sensitive reporter (dps promoter-gfp). Blue, strains that were experimentally measured to have higher levels of H 2 O 2 compared with wild type (P < 0.05); yellow, strains that were experimentally measured to have levels of H 2 O 2 that do not exceed those of wild type. (d) Experimentally measured relative fluorescence/A 600 of strains with the O 2 − -sensitive reporter (soxS promoter-gfp). Blue, strains that were experimentally measured to have increased levels of O 2 − compared with wild type (P < 0.05); yellow, strains that were experimentally measured to have levels of O 2 − that do not exceed those of wild type. * denotes genes that are essential in our media conditions. Gray denotes genes that were not experimentally examined (for consistency between diagrams, these genes were also denoted by gray in a and b, although in silico predictions were computed).
npg l e t t e r s color-coded in Figure 2 and Supplementary  Figure 1 . We selected isozymes for testing on the basis of literature evidence that suggested their removal would most closely reflect model assumptions, and we did not test deletions of pyruvate dehydrogenase and triose-phosphate isomerase because they did not grow in minimal glucose media (Supplementary Methods).
To measure O 2 − , we used a SoxR-controlled GFP-reporter system, whereas to measure H 2 O 2 , we used both an OxyR-controlled GFPreporter system and the direct-sensing HyPer protein (Online Methods). Our experimental results showed 80-90% qualitative agreement with our in silico predictions of H 2 O 2 and O 2 − production ( Fig. 2 and Supplementary  Fig. 1 ; correct predictions: dps-GFP: 19/21, soxS-GFP: 17/21, HyPer: 17/21). The probabilities that these levels of agreement would have occurred by chance, using the null hypothesis that random segregation of the 21 genes into targets and negative controls would match experimental results as well as predictions from our modeling approach, are 3.7 × 10 −4 (dps-GFP), 1.0 × 10 −2 (soxS-GFP) and 6.2 × 10 −3 (HyPer) (Online Methods). These experimental results suggest that our systems-level approach using model ensembles enables predictable tuning of ROS production in E. coli.
We next asked if increased basal production of O 2 − and/or H 2 O 2 would make such strains more susceptible to killing by oxidants. We tested the oxidants O 2 − (generated via menadione) and H 2 O 2 because of their inclusion in the model and importance for antibiotic action 3 ; we chose NaOCl (bleach) because it is used as a biocide. Strains chosen for testing of oxidant sensitivity were those with in silico predictions of increased production (targets) or unchanged production (negative controls) that was confirmed by experimental results (Fig. 2) . Our results indicate that increased basal production of O 2 − or H 2 O 2 generally increases microbial susceptibility to oxidative attack (Fig. 3) . Strains with genetic deletions that increase ROS production were more susceptible to oxidants, whereas the negative-control strains, which had wild-type production levels of ROS, did not. The probability this enrichment would have been observed by random selection is 2.5 × 10 −5 and demonstrates that increased production of O 2 − and H 2 O 2 can potentiate killing by oxidants. We note that some mutant strains predicted to increase ROS production conferred increased susceptibility to all oxidants tested (∆cyoA and ∆sdhC), whereas others showed selective increases in sensitivity (e.g., ∆zwf), suggesting that sensitivity to one oxidant does not always translate to other oxidants. This is not surprising, and likely derives from the differences in biochemical activity of the oxidants and the distinct cellular-death pathways they induce 20, 21 . Our results clearly demonstrate that increasing endogenous production is a robust strategy to enhance the susceptibility of microbes to oxidative stress.
Bactericidal antibiotics have been shown to share a common mechanism of cell death that involves the production of ROS 3 . We investigated whether increased basal production of ROS could potentiate the action of bactericidal antibiotics (the β-lactam ampicillin, the fluoroquinolones ofloxacin and ciprofloxacin, and the aminoglycoside gentamicin) ( Fig. 4) . Three of the validated targets (∆cyoA, ∆nuoG, ∆sdhC) had increased sensitivity to both β-lactam and fluoroquinolone antibiotics (Fig. 4a,b and Supplementary  Fig. 2a ) and one of the targets (∆pta) exhibited increased sensitivity to only fluoroquinolones ( Fig. 4b and Supplementary Fig. 2a) , whereas all of the negative-control strains displayed wild-type sensitivity to both antibiotic classes (Fig. 4c,d and Supplementary Fig. 2b) . Our approach therefore correctly predicted strain sensitivity to both β-lactams and fluoroquinolone antibiotics over 70% of the time. We also tested sensitivity to aminoglycosides, though we reasoned that increased killing, in general, would not be observed. This expectation was based on the fact that many of the gene deletions that increase basal ROS production negatively affect proton motive force, which is important for aminoglycoside uptake 22 . As expected, the negative controls had similar sensitivity to gentamicin as wild type, whereas many targets had decreased sensitivity ( Supplementary  Fig. 2c,d) . We note that ∆atpC had increased sensitivity toward gentamicin, which we believe may be the result of its positive impact on proton motive force 23 as well as its effect on basal ROS production. These data indicate that bactericidal antibiotic primary target npg l e t t e r s interactions must be enabled (e.g., by antibiotic uptake) to leverage ROS production as an adjuvant therapy. Accordingly, we expected and demonstrated that the activities of bacteriostatic antibiotics, which do not produce ROS 6 , are unaffected by increases in basal ROS production (Supplementary Fig. 3) .
We also asked whether chemical inhibition of one of the validated targets could increase sensitivity to oxidants and bactericidal antibiotic treatment. We treated wild type with carboxin, an inhibitor of succinate dehydrogenase, and measured susceptibility toward H 2 O 2 and ampicillin, respectively. Addition of carboxin alone had no effect on the growth of wild-type cells (Fig. 4e,f) . However, wildtype cells treated with H 2 O 2 and carboxin demonstrated increased sensitivity compared to wild-type cells treated with H 2 O 2 alone (Fig. 4e) . Similarly, wild-type cells treated with ampicillin and carboxin were more sensitive to the antibiotic than cells treated with ampicillin alone (Fig. 4f) . To more fully examine this synergy, we conducted a systematic drug screen spanning five concentrations for each compound (carboxin and ampicillin) including the untreated sample. This allowed us to calculate that carboxin concentrations of 250 µM or greater are synergistic with ampicillin concentrations of 7.5-10 µg/ml, using the Bliss Independence and Highest Single Agent models of drug synergism (Supplementary Fig. 4) . These results show that chemical inhibition of a predicted and validated target (succinate dehydrogenase) is sufficient to increase sensitivity to oxidative attack and antibiotic treatment. Although carboxin may not be suitable as an antibiotic adjuvant due to toxicity concerns (http://www.epa.gov/oppsrrd1/REDs/factsheets/0012fact_carboxin. pdf), validation that chemical inhibition of succinate dehydrogenase confers sensitivity similar to that of genetic perturbation opens the possibility of using chemical library screening to find nontoxic inhibitors of bacterial succinate dehydrogenase and other predicted targets. Chemical libraries have been successfully screened for compounds with antimicrobial properties against pathogenic bacteria 24 and our method complements this work by identifying novel enzyme targets for compounds that may have no antimicrobial properties alone, but which enhance the killing efficacy of current antibacterial agents.
Here we established a systems-based method to predictably tune microbial ROS production. By developing genome-scale ROS metabolic models, we were able to predict redistribution of ROS flux resulting from network perturbations and demonstrate experimentally that increased ROS flux can potentiate oxidative attack from antibiotic and biocide treatment. This approach allows rapid identification of antibacterial adjuvant targets and is translatable to other pathogens of interest, such as Mycobacterium tuberculosis, Staphylococcus aureus, Haemophilus influenzae and Salmonella typhimurium, for which metabolic reconstructions are available [25] [26] [27] [28] . In addition, the increasingly rapid construction of genome-scale metabolic models will extend the breadth of the technique 29 , opening up the possibility of using it to target newly identified resistant strains.
MeTHOdS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper. npg the relative survival curves in Supplementary Figure 4 (curves substantially lower than 1) where 7.5 and 10 µg/mL ampicillin synergize with carboxin concentrations from 250-1,000 µM.
ACknoWleDgMentS
Modeling E. coli ROS metabolism. Systems-level metabolic modeling was performed using flux balance analysis and the COBRA Toolbox 36 . Aerobic E. coli metabolism (O 2 uptake = −18.5 mmol/gDW/h 17 ) was modeled using iAF1260 with glucose (glucose uptake = −11 mmol/gDW/h 17 ) and ammonia as the sole carbon and nitrogen sources. The model was augmented with ROSgenerating reactions as described in the Supplementary Methods. Single-gene deletion analysis was done using the built-in COBRA function. Complete modeling details are provided in the Supplementary Methods. Statistical analysis of model performance. Statistical significance was assessed using the null hypothesis that random selection of genes would match experimental results as well as predictions from our modeling approach. For the GFP reporter systems, where N genes exhibited an increased ROS/BM compared to wild type (P < 0.05), and M genes did not (N + M: total number of genes tested), we identified the number of genes, P, our approach predicted to increase ROS/BM. We calculated the (a) total number of ways to pick P genes from N + M, and then calculated the (b) number of ways to pick P genes that would yield C correct predictions, C being defined as the correctly predicted number of genes our approach identified to increase ROS/BM. The ratio of (b)/(a) is the probability that random selection would yield the same frequency of correct predictions as our approach. Agreement was assessed by calculating the number of predictions that agreed with experimental results. For the O 2 − -sensing GFP reporter, 17 of the 21 genes (81%) experimentally tested qualitatively agreed with predictions, whereas for the H 2 O 2 -sensing GFP reporter, 19 of the 21 genes (90%) experimentally tested qualitatively agreed with predictions. Identical procedures were used in the analysis of HyPer results, except that a P value of 0.1 was used to identify genes that exhibited an increased H 2 O 2 /BM compared to wild type. For antimicrobial sensitivity assays, statistical significance was assessed similarly, except that N in this case is the number of genes that exhibited a twofold increase in susceptibility toward any oxidant after a treatment time of 2 h.
